Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
10,417 results
- Study of Repeat Intranodal Injection of Memgen’s Cancer Vaccine, Ad-ISF35, in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Complete Statistical AnalysisIndependent statistical analysis of Study of Repeat Intranodal Injection of Memgen's Cancer Vaccine, Ad-ISF35, in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): primary endpoint results, effect estimate with confidence interval, sample-size…
- Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting: Complete Statistical AnalysisIndependent statistical analysis of Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting: primary endpoint results, effect estimate with confidence…
- Study of Rivoglitazone in Type 2 Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of Study of Rivoglitazone in Type 2 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00484198).
- Study of Romiplostim for Chemotherapy Induced Thrombocytopenia: Complete Statistical AnalysisIndependent statistical analysis of Study of Romiplostim for Chemotherapy Induced Thrombocytopenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02052882).
- Study of Roxadustat in Non-Dialysis Chronic Kidney Disease Participants With Anemia: Complete Statistical AnalysisIndependent statistical analysis of Study of Roxadustat in Non-Dialysis Chronic Kidney Disease Participants With Anemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of RSVpreF Vaccination and RSV Challenge in Healthy Adults: Complete Statistical AnalysisIndependent statistical analysis of Study of RSVpreF Vaccination and RSV Challenge in Healthy Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04785612).
- Study of Ruxolitinib in Colorectal Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Study of Ruxolitinib in Colorectal Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02119676).
- Study of Ruxolitinib in Pancreatic Cancer Patients (Janus 1): Complete Statistical AnalysisIndependent statistical analysis of Study of Ruxolitinib in Pancreatic Cancer Patients (Janus 1): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02117479).
- Study of Safety and Efficacy of an Oral Contraceptive: Complete Statistical AnalysisIndependent statistical analysis of Study of Safety and Efficacy of an Oral Contraceptive: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00391807).
- Study of Safety and Efficacy of an Oral Contraceptive: Complete Statistical AnalysisIndependent statistical analysis of Study of Safety and Efficacy of an Oral Contraceptive: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00932321).
- Study of Safety and Efficacy of Brolucizumab 6 mg Drug Product Intended for Commercialization in Patients With nAMD: Complete Statistical AnalysisIndependent statistical analysis of Study of Safety and Efficacy of Brolucizumab 6 mg Drug Product Intended for Commercialization in Patients With nAMD: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Study Of Safety And Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes (MK-8835-016): Complete Statistical AnalysisIndependent statistical analysis of Study Of Safety And Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes (MK-8835-016): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of Safety and Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes And Hypertension (MK-8835-042): Complete Statistical AnalysisIndependent statistical analysis of Study of Safety and Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes And Hypertension (MK-8835-042): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Study of Safety and Efficacy of Talimogene Laherparepvec With Cisplatin and Radiotherapy for Treatment of Locally Advanced Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Safety and Efficacy of Talimogene Laherparepvec With Cisplatin and Radiotherapy for Treatment of Locally Advanced Head and Neck Cancer: primary endpoint results, effect estimate with confidence…
- Study of Safety and Immunogenicity of Fluzone® in Healthy Children: Complete Statistical AnalysisIndependent statistical analysis of Study of Safety and Immunogenicity of Fluzone® in Healthy Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00831675).
- Study of Safety, Pharmacokinetics, and Antitumor Activity of BGB-3245 in Participants With Advanced or Refractory Tumors: Complete Statistical AnalysisIndependent statistical analysis of Study of Safety, Pharmacokinetics, and Antitumor Activity of BGB-3245 in Participants With Advanced or Refractory Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of Safety, Tolerability and Immunogenicity of Gardasil®9 in Immunocompromised Patients: Complete Statistical AnalysisIndependent statistical analysis of Study of Safety, Tolerability and Immunogenicity of Gardasil®9 in Immunocompromised Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of Safety, Tolerability, and Efficacy of Ustekinumab for Symptomatic Gastrointestinal Inflammation Associated With Common Variable Immunodeficiency: Complete Statistical AnalysisIndependent statistical analysis of Study of Safety, Tolerability, and Efficacy of Ustekinumab for Symptomatic Gastrointestinal Inflammation Associated With Common Variable Immunodeficiency: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study of Safety, Tolerability, Pharmacokinetics, and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Study of Safety, Tolerability, Pharmacokinetics, and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of Saxagliptin, 5-Hydroxy Saxagliptin, and Metformin Concentrations/Levels in Pediatric Subjects With T2DM: Complete Statistical AnalysisIndependent statistical analysis of Study of Saxagliptin, 5-Hydroxy Saxagliptin, and Metformin Concentrations/Levels in Pediatric Subjects With T2DM: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Selective BRAF Kinase Inhibitor Dabrafenib Monotherapy Twice Daily and in Combination With Dabrafenib Twice Daily and Trametinib Once Daily in Combination Therapy in Subjects With BRAF V600E Mutation Positive Metastatic (Stage IV) Non-small Cell Lung Cancer.: Complete Statistical AnalysisIndependent statistical analysis of Study of Selective BRAF Kinase Inhibitor Dabrafenib Monotherapy Twice Daily and in Combination With Dabrafenib Twice Daily and Trametinib Once Daily in Combination Therapy in Subjects With BRAF…
- Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260): Complete Statistical AnalysisIndependent statistical analysis of Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Study of Sonrotoclax (BGB-11417) Monotherapy in Participants With Relapsed or Refractory Mantle Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Study of Sonrotoclax (BGB-11417) Monotherapy in Participants With Relapsed or Refractory Mantle Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of SPM 962 in Patients With Restless Legs Syndrome (RLS): Complete Statistical AnalysisIndependent statistical analysis of Study of SPM 962 in Patients With Restless Legs Syndrome (RLS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of SPR001 in Adults With Classic Congenital Adrenal Hyperplasia: Complete Statistical AnalysisIndependent statistical analysis of Study of SPR001 in Adults With Classic Congenital Adrenal Hyperplasia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03257462).
- Study Of SU011248 In Combination With Docetaxel In Patients With Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study Of SU011248 In Combination With Docetaxel In Patients With Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Subcutaneous Risankizumab Injection Compared to Oral Apremilast Tablets to Assess Change in Disease Activity And Adverse Events in Adult Participants With Moderate Plaque Psoriasis Who Are Candidates for Systemic Therapy: Complete Statistical AnalysisIndependent statistical analysis of Study of Subcutaneous Risankizumab Injection Compared to Oral Apremilast Tablets to Assess Change in Disease Activity And Adverse Events in Adult Participants With Moderate Plaque Psoriasis Who Are…
- Study Of Sunitinib With Capecitabine In Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study Of Sunitinib With Capecitabine In Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00662025).
- Study Of Sunitinib With S-1 And Cisplatin For Gastric Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study Of Sunitinib With S-1 And Cisplatin For Gastric Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00553696).
- Study of Tadalafil Once-a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia: Complete Statistical AnalysisIndependent statistical analysis of Study of Tadalafil Once-a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Study of TAK-228 In Patients With Previously Treated Metastatic Renal Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Study of TAK-228 In Patients With Previously Treated Metastatic Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Talimogene Laherparepvec In Children With Advanced Non CNS Tumors: Complete Statistical AnalysisIndependent statistical analysis of Study of Talimogene Laherparepvec In Children With Advanced Non CNS Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of TBL 12 Sea Cucumber Extract for Patients With Untreated Asymptomatic Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Study of TBL 12 Sea Cucumber Extract for Patients With Untreated Asymptomatic Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of TDM-105795 Following Topical Administration in Male Subjects With Androgenetic Alopecia: Complete Statistical AnalysisIndependent statistical analysis of Study of TDM-105795 Following Topical Administration in Male Subjects With Androgenetic Alopecia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Tecemotide (L-BLP25) in Subjects With Slowly Progressive Multiple Myeloma With no Symptoms and Who Have Had no Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Study of Tecemotide (L-BLP25) in Subjects With Slowly Progressive Multiple Myeloma With no Symptoms and Who Have Had no Chemotherapy: primary endpoint results, effect estimate with confidence interval,…
- Study of Teduglutide in Japanese Participants With Short Bowel Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Study of Teduglutide in Japanese Participants With Short Bowel Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03663582).
- Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (ADACEL®) as a Booster in Adolescents: Complete Statistical AnalysisIndependent statistical analysis of Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (ADACEL®) as a Booster in Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study of the Aliviado DSD Caregiving Mastery Program: Complete Statistical AnalysisIndependent statistical analysis of Study of the Aliviado DSD Caregiving Mastery Program: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05630014).
- Study of the Bioequivalence of the 20% and 30% Etoricoxib Tablet Formulations (0663-070): Complete Statistical AnalysisIndependent statistical analysis of Study of the Bioequivalence of the 20% and 30% Etoricoxib Tablet Formulations (0663-070): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of the Bruton’s Tyrosine Kinase Inhibitor in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites: Complete Statistical AnalysisIndependent statistical analysis of Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites: primary endpoint results, effect estimate with confidence interval, sample-size…
- Study of the Effect of Ivacaftor on Lung Clearance Index in Subjects With Cystic Fibrosis and the G551D Mutation: Complete Statistical AnalysisIndependent statistical analysis of Study of the Effect of Ivacaftor on Lung Clearance Index in Subjects With Cystic Fibrosis and the G551D Mutation: primary endpoint results, effect estimate with confidence interval, sample-size…
- Study of the Effects of an Antidepressant Medication and Placebo on the Brain Functioning of Normal Subjects: Complete Statistical AnalysisIndependent statistical analysis of Study of the Effects of an Antidepressant Medication and Placebo on the Brain Functioning of Normal Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study of the Effects of HIRREM-SOP for Insomnia: Complete Statistical AnalysisIndependent statistical analysis of Study of the Effects of HIRREM-SOP for Insomnia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03607994).
- Study of the Effects of Itraconazole and Rifampin on LOXO-305 in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of Study of the Effects of Itraconazole and Rifampin on LOXO-305 in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of the Effects of Motivational Enhancement Therapy on Alcohol Use in Chronic Hepatitis C Patients: Complete Statistical AnalysisIndependent statistical analysis of Study of the Effects of Motivational Enhancement Therapy on Alcohol Use in Chronic Hepatitis C Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of the Effects of Oral AT1001 (Migalastat Hydrochloride) in Patients With Fabry Disease: Complete Statistical AnalysisIndependent statistical analysis of Study of the Effects of Oral AT1001 (Migalastat Hydrochloride) in Patients With Fabry Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of the Efficacy and Safety of Alirocumab (REGN727/SAR236553) in Combination With Other Lipid-modifying Treatment (LMT) (ODYSSEY OPTIONS I): Complete Statistical AnalysisIndependent statistical analysis of Study of the Efficacy and Safety of Alirocumab (REGN727/SAR236553) in Combination With Other Lipid-modifying Treatment (LMT) (ODYSSEY OPTIONS I): primary endpoint results, effect estimate with confidence interval, sample-size…
- Study of the Efficacy and Safety of Nebivolol in Younger Patients (18 – 54 Years): Complete Statistical AnalysisIndependent statistical analysis of Study of the Efficacy and Safety of Nebivolol in Younger Patients (18 - 54 Years): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…